Orange Book product · Brand (NDA)
CETYLEV
ACETYLCYSTEINE
At a glance
Jan 29, 2016
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 29, 2016
10 yr 6 mo ago
Today
Patent 8747894 expires
Listed drug product patent expiration.
May 08, 2032
in 6 yr
Patent 9427421 expires
Listed drug product patent expiration.
May 08, 2032
in 6 yr
Patent 9561204 expires
Listed method-of-use patent (U-1373) expiration.
May 08, 2032
in 6 yr
Pharmaceutical detail
Active ingredient
ACETYLCYSTEINE
Strength
2.5GM
Dosage form
TABLET, EFFERVESCENT
Route
ORAL
TE code
Not listed
Application
NDA 207916
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2004ACETADOTEBrand (NDA)
NDA 021539 · CUMBERLAND PHARMS
- —MUCOMYSTBrand (NDA)
NDA 013601 · APOTHECON
- 2025ACETYLCYSTEINEGeneric (ANDA)
ANDA 214177 · CONBA USA
- 2025ACETYLCYSTEINEGeneric (ANDA)
ANDA 219194 · SOMERSET THERAPS LLC
- 2024ACETYLCYSTEINEGeneric (ANDA)
ANDA 218397 · SOMERSET THERAPS LLC
- 2023ACETYLCYSTEINEGeneric (ANDA)
ANDA 205643 · EXELA PHARMA
- 2023ACETYLCYSTEINEGeneric (ANDA)
ANDA 217182 · ONESOURCE SPECIALTY
- 2022ACETYLCYSTEINEGeneric (ANDA)
ANDA 215620 · REGCON HOLDINGS
- 2022ACETYLCYSTEINEGeneric (ANDA)
ANDA 213693 · GLENMARK PHARMS
- 2021ACETYLCYSTEINEGeneric (ANDA)
ANDA 204797 · EXELA PHARMA
- 2018ACETYLCYSTEINEGeneric (ANDA)
ANDA 208166 · ZYDUS PHARMS
- 2017ACETYLCYSTEINEGeneric (ANDA)
ANDA 091684 · SAGENT PHARMS INC
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8747894 | May 08, 2032 | in 6 yr | ProductU-1373 |
| 9427421 | May 08, 2032 | in 6 yr | Product |
| 9561204 | May 08, 2032 | in 6 yr | U-1373 |

